Mitochondrial Damage of Lymphocytes in Patients with Acute Relapse of Schizophrenia: A Correlational Study with Efficacy and Clinical Symptoms

References

• Insel TR. Rethinking schizophrenia. Nature. 2010;468(7321):187–193. doi:10.1038/nature09552
   PubMed Web of Science ®Google Scholar
• McGlashan TH. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull. 1988;14(4):515–542. doi:10.1093/schbul/14.4.515
   PubMed Web of Science ®Google Scholar
• Charlson FJ, Ferrari AJ, Santomauro DF, et al. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull. 2018;44(6):1195–1203. doi:10.1093/schbul/sby058
   PubMed Web of Science ®Google Scholar
• Müller N, Riedel M, Gruber R, et al. The immune system and schizophrenia. An integrative view. Ann N Y Acad Sci. 2000;917(1):456–467. doi:10.1111/j.1749-6632.2000.tb05410.x
   Google Scholar
• Müller N. Immunological aspects of the treatment of depression and schizophrenia. Dialogues Clin Neurosci. 2017;19(1):55–63. doi:10.31887/DCNS.2017.19.1/nmueller
   PubMed Web of Science ®Google Scholar
• Ganguli R, Brar JS, Rabin BS. Immune abnormalities in schizophrenia: evidence for the autoimmune hypothesis. Harv Rev Psychiatry. 1994;2(2):70–83. doi:10.3109/10673229409017120
   Web of Science ®Google Scholar
• Khandaker GM, Cousins L, Deakin J, et al. Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry. 2015;2(3):258–270. doi:10.1016/S2215-0366(14)00122-9
   PubMed Web of Science ®Google Scholar
• Manji H, Kato T, Di Prospero NA, et al. Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci. 2012;13(5):293–307. doi:10.1038/nrn3229
   PubMed Web of Science ®Google Scholar
• Anderson G, Berk M, Dodd S, et al. Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013;42:1–4. doi:10.1016/j.pnpbp.2012.10.008
   PubMed Web of Science ®Google Scholar
• Nawa H, Takei N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci Res. 2006;56(1):2–13. doi:10.1016/j.neures.2006.06.002
   Web of Science ®Google Scholar
• Busse S, Busse M, Schiltz K, et al. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations? Brain Behav Immun. 2012;26(8):1273–1279. doi:10.1016/j.bbi.2012.08.005
   PubMed Web of Science ®Google Scholar
• Schlaaff K, Dobrowolny H, Frodl T, et al. Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients. Brain Behav Immun. 2020;88:497–506. doi:10.1016/j.bbi.2020.04.021
   Web of Science ®Google Scholar
• Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(3):559–576. doi:10.1016/j.pnpbp.2004.01.009
   PubMed Web of Science ®Google Scholar
• Kim Y, Vadodaria KC, Lenkei Z, et al. Mitochondria, metabolism, and redox mechanisms in psychiatric disorders. Antioxid Redox Signal. 2019;31(4):275–317. doi:10.1089/ars.2018.7606
   PubMed Web of Science ®Google Scholar
• Lemasters JJ. Modulation of mitochondrial membrane permeability in pathogenesis, autophagy and control of metabolism. J Gastroenterol Hepatol. 2007;22(Suppl 1):S31–37. doi:10.1111/j.1440-1746.2006.04643.x
   Web of Science ®Google Scholar
• Kowaltowski AJ, Castilho RF, Vercesi AE. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 2001;495(1–2):12–15. doi:10.1016/s0014-5793(01)02316-x
   PubMed Web of Science ®Google Scholar
• Zamzami N, Susin SA, Marchetti P, et al. Mitochondrial control of nuclear apoptosis. J Exp Med. 1996;183(4):1533–1544. doi:10.1084/jem.183.4.1533
   PubMed Web of Science ®Google Scholar
• Kantrow SP, Tatro LG, Piantadosi CA. Oxidative stress and adenine nucleotide control of mitochondrial permeability transition. Free Radic Biol Med. 2000;28(2):251–260. doi:10.1016/s0891-5849(99)00238-5
   Web of Science ®Google Scholar
• Yarana C, Sripetchwandee J, Sanit J, et al. Calcium-induced cardiac mitochondrial dysfunction is predominantly mediated by cyclosporine A-dependent mitochondrial permeability transition pore. Arch Med Res. 2012;43(5):333–338. doi:10.1016/j.arcmed.2012.06.010
   PubMed Web of Science ®Google Scholar
• Kim JS, He L, Lemasters JJ. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun. 2003;304(3):463–470. doi:10.1016/s0006-291x(03)00618-1
   PubMed Web of Science ®Google Scholar
• Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol. 2007;19(1):39–45. doi:10.1016/j.coi.2006.11.007
   PubMed Web of Science ®Google Scholar
• Rajasekaran A, Venkatasubramanian G, Berk M, et al. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev. 2015;48:10–21. doi:10.1016/j.neubiorev.2014.11.005
   PubMed Web of Science ®Google Scholar
• Pedrini M, Massuda R, Fries GR, et al. Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity. J Psychiatr Res. 2012;46(6):819–824. doi:10.1016/j.jpsychires.2012.03.019
   PubMed Web of Science ®Google Scholar
• Martínez-Cengotitabengoa M, Mac-Dowell KS, Leza JC, et al. Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes. Schizophr Res. 2012;137(1–3):66–72. doi:10.1016/j.schres.2012.03.004
   PubMed Web of Science ®Google Scholar
• Engelhardt B, Sorokin L. The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol. 2009;31(4):497–511. doi:10.1007/s00281-009-0177-0
   PubMed Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46–56. doi:10.1038/nrn2297
   PubMed Web of Science ®Google Scholar
• Wood SJ, Yücel M, Pantelis C, et al. Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Ann Acad Med Singap. 2009;38(5):396.
   Web of Science ®Google Scholar
• Ben-Shachar D, Ene HM. Mitochondrial targeted therapies: where do we stand in mental disorders? Biol Psychiatry. 2018;83:770–779. doi:10.1016/j.biopsych.2017.08.007
   Web of Science ®Google Scholar
• Kung L, Roberts RC. Mitochondrial pathology in human schizophrenic striatum: a postmortem ultrastructural study. Synapse. 1999;31:67–75. doi:10.1002/(sici)1098-2396(199901)31:1<67::Aid-syn9>3.0.Co;2-#
   PubMed Web of Science ®Google Scholar
• Uranova N, Orlovskaya D, Vikhreva O, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 2001;55:597–610. doi:10.1016/s0361-9230(01)00528-7
   PubMed Web of Science ®Google Scholar
• Yu F, Hao Y, Zhao H, et al. Distinct mitochondrial disturbance in CD4+T and CD8+T cells from HIV-infected patients. J Acquir Immune Defic Syndr. 2017;74:206–212. doi:10.1097/qai.0000000000001175
   PubMed Web of Science ®Google Scholar
• Pang LX, Cai WW, Chen L, et al. The diagnostic value of mitochondrial mass of peripheral T lymphocytes in early sepsis. Front Public Health. 2022;10:928306. doi:10.3389/fpubh.2022.928306
   PubMed Web of Science ®Google Scholar
• Scaini G, Mason BL, Diaz AP, et al. Dysregulation of mitochondrial dynamics, mitophagy and apoptosis in major depressive disorder: does inflammation play a role? Mol Psychiatry. 2022;27:1095–1102. doi:10.1038/s41380-021-01312-w
   Web of Science ®Google Scholar
• Puleston D. Detection of mitochondrial mass, damage, and reactive oxygen species by flow cytometry. Cold Spring Harb Protoc. 2015;2015:pdb.prot086298. doi:10.1101/pdb.prot086298
   Google Scholar
• Clutton G. Corrigendum: a reproducible, objective method using MitoTracker® fluorescent dyes to assess mitochondrial mass in T cells by flow cytometry. Cytometry A. 2021;99:753. doi:10.1002/cyto.a.24346
   Web of Science ®Google Scholar
• Wright J, Gray AH, Bruce L, et al. Clinical Pharmacy Pocket Companion. Pharmaceutical Press; 2015.
   Google Scholar
• Robicsek O, Karry R, Petit I, et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry. 2013;18:1067–1076. doi:10.1038/mp.2013.67
   PubMed Web of Science ®Google Scholar
• Ben-Shachar D. Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target. Schizophr Res. 2017;187:3–10. doi:10.1016/j.schres.2016.10.022
   PubMed Web of Science ®Google Scholar
• Cooper JM, Schapira AH. Mitochondrial dysfunction in neurodegeneration. J Bioenerg Biomembr. 1997;29:175–183. doi:10.1023/a:1022642114734
   PubMed Web of Science ®Google Scholar
• Castora FJ. Mitochondrial function and abnormalities implicated in the pathogenesis of ASD. Prog Neuropsychopharmacol Biol Psychiatry. 2019;92:83–108. doi:10.1016/j.pnpbp.2018.12.015
   Web of Science ®Google Scholar
• Picca A, Calvani R, Coelho-Junior HJ, et al. Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration. Antioxidants. 2020;9. doi:10.3390/antiox9080647
   Web of Science ®Google Scholar
• Anglin RE, Tarnopolsky MA, Mazurek MF, et al. The psychiatric presentation of mitochondrial disorders in adults. J Neuropsychiatry Clin Neurosci. 2012;24:394–409. doi:10.1176/appi.neuropsych.11110345
   Web of Science ®Google Scholar
• Kramer P, Bressan P. Our (Mother’s) mitochondria and our mind. Perspect Psychol Sci. 2018;13:88–100. doi:10.1177/1745691617718356
   Google Scholar
• Kvajo M, Dhilla A, Swor DE, et al. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry. 2008;13:685–696. doi:10.1038/sj.mp.4002052
   PubMed Web of Science ®Google Scholar
• Karry R, Klein E, Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol Psychiatry. 2004;55:676–684. doi:10.1016/j.biopsych.2003.12.012
   PubMed Web of Science ®Google Scholar
• Roberts RC. Mitochondrial dysfunction in schizophrenia: with a focus on postmortem studies. Mitochondrion. 2021;56:91–101. doi:10.1016/j.mito.2020.11.009
   PubMed Web of Science ®Google Scholar
• Takahashi Y. An enzymological study on brain tissue of schizophrenic patients. carbohydrate metabolism. Part I. Glucose. Psychiatry Clin Neurosci. 1953;7:214–237.
   Google Scholar
• Uranova NA, Vikhreva OV, Rakhmanova VI, et al. Ultrastructural pathology of oligodendrocytes adjacent to microglia in prefrontal white matter in schizophrenia. NPJ Schizophr. 2018;4:26. doi:10.1038/s41537-018-0068-2
   Web of Science ®Google Scholar
• Uranova NA, Vikhreva OV, Rakhmanova VI, et al. Dystrophy of oligodendrocytes and adjacent microglia in prefrontal gray matter in schizophrenia. Front Psychiatry. 2020;11:204. doi:10.3389/fpsyt.2020.00204
   Web of Science ®Google Scholar
• Uranova N, Bonartsev P, Brusov O, et al. The ultrastructure of lymphocytes in schizophrenia. World J Biol Psychiatry. 2007;8:30–37. doi:10.1080/15622970600960207
   PubMed Web of Science ®Google Scholar
• Inuwa IM, Peet M, Williams MA. QSAR modeling and transmission electron microscopy stereology of altered mitochondrial ultrastructure of white blood cells in patients diagnosed as schizophrenic and treated with antipsychotic drugs. Biotech Histochem. 2005;80:133–137. doi:10.1080/10520290500303349
   PubMed Web of Science ®Google Scholar
• Park C and Park S Ki. (2012). Molecular links between mitochondrial dysfunctions and schizophrenia. Mol Cells, 33(2), 105–110. doi:10.1007/s10059-012-2284-3
   Web of Science ®Google Scholar
• Chestkov IV, Jestkova EM, Ershova ES, et al. ROS-induced DNA damage associates with abundance of mitochondrial DNA in white blood cells of the untreated schizophrenic patients. Oxid Med Cell Longev. 2018;2018:8587475. doi:10.1155/2018/8587475
   Web of Science ®Google Scholar
• Rosenfeld M, Brenner-Lavie H, Ari SG, et al. Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia. Biol Psychiatry. 2011;69:980–988. doi:10.1016/j.biopsych.2011.01.010
   Web of Science ®Google Scholar
• Amiri S, Dizaji R, Momeny M, et al. Clozapine attenuates mitochondrial dysfunction, inflammatory gene expression, and behavioral abnormalities in an animal model of schizophrenia. Neuropharmacology. 2021;187:108503. doi:10.1016/j.neuropharm.2021.108503
   Web of Science ®Google Scholar
• Tianyi Z, Shize L, Yichuan L, et al. Study on the mitochondrial mass of peripheral blood immune cells in patients with schizophrenia. Chin J Psychiatry. 2022:254–262. doi:10.3760/cma.j.cn113661-20220322-00068.
   Google Scholar
• Miller BJ, Gassama B, Sebastian D, et al. Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2013;73:993–999. doi:10.1016/j.biopsych.2012.09.007
   PubMed Web of Science ®Google Scholar
• Maino K, Gruber R, Riedel M, et al. T- and B-lymphocytes in patients with schizophrenia in acute psychotic episode and the course of the treatment. Psychiatry Res. 2007;152:173–180. doi:10.1016/j.psychres.2006.06.004
   PubMed Web of Science ®Google Scholar
• Faas MM, de Vos P. Mitochondrial function in immune cells in health and disease. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165845. doi:10.1016/j.bbadis.2020.165845
   PubMed Web of Science ®Google Scholar
• Chan ST, McCarthy MJ, Vawter MP. Psychiatric drugs impact mitochondrial function in brain and other tissues. Schizophr Res. 2020;217:136–147. doi:10.1016/j.schres.2019.09.007
   Web of Science ®Google Scholar
• Möller M, Du Preez JL, Viljoen FP, et al. Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine. Brain Behav Immun. 2013;30:156–167. doi:10.1016/j.bbi.2012.12.011
   PubMed Web of Science ®Google Scholar
• Bar-Yosef T, Hussein W, Yitzhaki O, et al. Mitochondrial function parameters as a tool for tailored drug treatment of an individual with psychosis: a proof of concept study. Sci Rep. 2020;10:12258. doi:10.1038/s41598-020-69207-4
   Web of Science ®Google Scholar
• Sultana R, Baglioni M, Cecchetti R, et al. Lymphocyte mitochondria: toward identification of peripheral biomarkers in the progression of Alzheimer disease. Free Radic Biol Med. 2013;65:595–606. doi:10.1016/j.freeradbiomed.2013.08.001
   PubMed Web of Science ®Google Scholar
• Sultana R, Mecocci P, Mangialasche F, et al. Increased protein and lipid oxidative damage in mitochondria isolated from lymphocytes from patients with Alzheimer’s disease: insights into the role of oxidative stress in Alzheimer’s disease and initial investigations into a potential biomarker for this dementing disorder. J Alzheimers Dis. 2011;24:77–84. doi:10.3233/jad-2011-101425
   PubMed Web of Science ®Google Scholar
• Leirer DJ, Iyegbe CO, Di Forti M, et al. Differential gene expression analysis in blood of first episode psychosis patients. Schizophr Res. 2019;209:88–97. doi:10.1016/j.schres.2019.05.011
   PubMed Web of Science ®Google Scholar
• Goetzl EJ, Srihari VH, Guloksuz S, et al. Neural cell-derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosis. FASEB j. 2021;35:e21339. doi:10.1096/fj.202002519R
   Web of Science ®Google Scholar
• Bruno A, Pandolfo G, Crucitti M, et al. Acetyl-L-carnitine augmentation of clozapine in partial-responder schizophrenia: a 12-week, open-label uncontrolled preliminary study. Clin Neuropharmacol. 2016;39:277–280. doi:10.1097/wnf.0000000000000170
   PubMed Web of Science ®Google Scholar